Media Release
03 April 2008
Pharmac To Reconsider Herceptin Funding
The eight breast cancer patients who took their case to the High Court seeking the overturning of Pharmac’s funding
decisions for the cancer drug Herceptin can take some comfort from the High Court decision that Pharmac must reconsider
and consult over its decision not to fund 12 months of Herceptin for women with early breast cancer, says New Zealand
First health spokesperson Barbara Stewart.
“The ball is now back in Pharmac’s court.
“The court case will have been immensely stressful for all those involved and the review of this decision must not be
dragged out any longer than is absolutely essential,” said Mrs Stewart.
ENDS